2-MMC
2-MMC is a substituted cathinone1 and designer drug with stimulant and entactogenic properties. First identified in Sweden in 2014, it is a positional isomer of the better-known 3-MMC and mephedrone (4-MMC).12 Despite its cathinone structure, its effects have been compared more closely to those of amphetamine and 2-FA, leaning toward functional stimulation. As a research chemical, limited data exists regarding its safety profile and long-term effects.
Dosage & Duration
Dosage
Subjective Effects
2-MMC is described as a stimulant with euphoric effects. Despite its chemical relationship to cathinones such as mephedrone and 3-MMC, its effects are characterized as resembling those of 2-FA or amphetamine more closely than other substituted cathinones.
Physical
The substance is documented as stimulating.
Cognitive
Euphoria is the primary reported mental effect.
Pharmacology
Pharmacodynamics
2-MMC acts as a releasing agent at the serotonin, norepinephrine, and dopamine transporters, with a higher preference for the norepinephrine and dopamine transporters relative to the serotonin transporter.3
Pharmacokinetics
There have been no studies on the pharmacokinetic profile of 2-MMC and the metabolism of 2-MMC is unknown.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
Classified as habit-forming, suggesting potential for psychological dependence, though specific risk data is not available for this research chemical.
History & Culture
2-Methylmethcathinone emerged as a novel psychoactive substance during the mid-2010s wave of synthetic cathinone proliferation. The compound was first identified by Swedish authorities in 20142, representing one of the later positional isomers of mephedrone to appear…
Legality
By Country
References
Source Pages
Citations
- John D Power, Peggy McGlynn, Karen Clarke, Seán D McDermott, Pierce Kavanagh, & John O'Brien. (2011). The analysis of substituted cathinones. Part 1: chemical analysis of 2-, 3- and 4-methylmethcathinone. 212, 6-12. https://doi.org/10.1016/j.forsciint.2011.04.02012
- EUDA Initial Report on the New Psychoactive Substance 2-MMC (2-Methylmethcathinone). European Union Drugs Agency (EUDA) (2025). https://www.euda.europa.eu/system/files/documents/2025-07/initial-report-on-2-mmc.pdf1234
- Donna Walther, Abdelrahman R Shalabi, Michael H Baumann, & Richard A Glennon. (January 2019). Systematic Structure-Activity Studies on Selected 2-, 3-, and 4-Monosubstituted Synthetic Methcathinone Analogs as Monoamine Transporter Releasing Agents. ACS Chem Neurosci, 10(1), 740–745. https://doi.org/10.1021/acschemneuro.8b005241
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2026L00633/asmade/2026-05-28/text/original/epub/OEBPS/document_1/document_1.html1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2019L00561/2025-03-01/2025-03-01/text/original/epub/OEBPS/document_1/document_1.html1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. legislation.gov.au (n.d.). https://www.legislation.gov.au/F1996B03651/2026-03-26/2026-03-26/text/original/epub/OEBPS/document_1/document_1.html1
- Suchtgiftverordnung, Anhang IV.2. ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/NormDokument.wxe?Abfrage=Bundesnormen&Anlage=4&Artikel=&Gesetzesnummer=10011053&Paragraf=&Uebergangsrecht=1
- Portaria SVS/MS nº 344/1998, Anexo I, Lista F2(c), as updated by RDC ANVISA nº 1.021/2026. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=detalharAto&cod_menu=1696&cod_modulo=134&desItem=&desItemFim=&nomeTitulo=codigos&numeroAto=00001021&orgao=RDC%2FDC%2FANVISA%2FMS&pesquisa=true&seqAto=000&tipo=RDC&valorAno=20261
- Portaria SVS/MS nº 344/1998, Anexo I, Lista F2(c), as updated by RDC ANVISA nº 1.021/2026. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias1
- Bekendtgørelse om euforiserende stoffer (BEK nr. 405 af 26/03/2026). retsinformation.dk (n.d.). https://www.retsinformation.dk/api/pdf/2559321
- Betäubungsmittelgesetz (BtMG). gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html1
- Betäubungsmittelgesetz (BtMG). gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/__3.html1
- Betäubungsmittelgesetz (BtMG). gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/__13.html1
- Betäubungsmittelgesetz (BtMG). gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/__29.html1
- Schedule 1, Misuse of Drugs Regulations 2017 (as substituted by S.I. No. 210/2022). irishstatutebook.ie (n.d.). https://www.irishstatutebook.ie/eli/2022/si/210/made/en/print1
- Schedule 1, Misuse of Drugs Regulations 2017 (as substituted by S.I. No. 210/2022). irishstatutebook.ie (n.d.). https://www.irishstatutebook.ie/eli/2022/si/211/made/en/print1
- Schedule 1, Misuse of Drugs Regulations 2017 (as substituted by S.I. No. 210/2022). irishstatutebook.ie (n.d.). https://www.irishstatutebook.ie/eli/2025/si/405/made/en/print1
- Ministero della Salute, decreto 16 dicembre 2025 (25A06899), Tabella I del DPR 9 ottobre 1990, n. 309. gazzettaufficiale.it (n.d.). https://www.gazzettaufficiale.it/atto/vediMenuHTML?atto.dataPubblicazioneGazzetta=2025-12-29&atto.codiceRedazionale=25A06899&tipoSerie=serie_generale&tipoVigenza=originario1
- Opiumwet, List IA, substance group 1. wetten.overheid.nl (n.d.). https://wetten.overheid.nl/BWBR0001941/1
- Forskrift om narkotika (narkotikaforskriften). lovdata.no (n.d.). https://lovdata.no/forskrift/2024-02-29-3571
- Otwarta lista zidentyfikowanych i kontrolowanych nowych substancji psychoaktywnych. gov.pl (n.d.). https://www.gov.pl/web/gis/otwarta-lista-zidentyfikowanych-i-kontrolowanych-nowych-substancji-psychoaktywnych1
- Otwarta lista zidentyfikowanych nowych substancji psychoaktywnych objętych wzorem ogólnym i/lub przypisem rozporządzenia. gov.pl (n.d.). https://www.gov.pl/attachment/d16e77d3-78d3-4a2a-b626-d0a0421bf33e1
- Rozporządzenie Ministra Zdrowia w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych. eli.gov.pl (n.d.). https://eli.gov.pl/api/acts/DU/2024/1139/text.html1
- Portaria n.º 154/2013, as republished and amended by Portaria n.º 232/2022, under Decreto-Lei n.º 54/2013. files.diariodarepublica.pt (n.d.). https://files.diariodarepublica.pt/1s/2022/09/17300/0000400008.pdf1
- Singapore Statutes Online — Misuse of Drugs Act 1973, First Schedule. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/Act/MDA1973?ProvIds=Sc1-1
- Orden SND/362/2026, de 13 de abril, por la que se modifica el anexo 1 del Real Decreto 2829/1977, de 6 de octubre; Real Decreto 2829/1977, de 6 de octubre (texto consolidado). boe.es (n.d.). https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-87001
- Orden SND/362/2026, de 13 de abril, por la que se modifica el anexo 1 del Real Decreto 2829/1977, de 6 de octubre; Real Decreto 2829/1977, de 6 de octubre (texto consolidado). boe.es (n.d.). https://www.boe.es/buscar/act.php?id=BOE-A-1977-271601
- Förordning (1992:1554) om kontroll av narkotika. riksdagen.se (n.d.). https://www.riksdagen.se/sv/dokument-och-lagar/dokument/svensk-forfattningssamling/forordning-19921554-om-kontroll-av-narkotika_sfs-1992-1554/1
- SFS 2019:24, Förordning om ändring i förordningen (1992:1554) om kontroll av narkotika. svenskforfattningssamling.se (n.d.). https://svenskforfattningssamling.se/sites/default/files/sfs/2019-02/SFS2019-24.pdf1
- Misuse of Drugs Act 1971 — Schedule 2, Part II, paragraph 1(aa) (cathinone derivatives). legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/schedule/212
- Misuse of Drugs Act 1971. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/section/41
- Misuse of Drugs Act 1971. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/section/51
- Misuse of Drugs Act 1971 — Schedule 4, Part II (Class B penalties). (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/schedule/41
- Controlled Substances Act. govinfo.gov (n.d.). https://www.govinfo.gov/content/pkg/USCODE-2023-title21/pdf/USCODE-2023-title21-chap13-subchapI-partA-sec802.pdf1
- Controlled Substances Act. govinfo.gov (n.d.). https://www.govinfo.gov/content/pkg/USCODE-2023-title21/pdf/USCODE-2023-title21-chap13-subchapI-partB-sec812.pdf1
- Controlled Substances Act. ecfr.gov (n.d.). https://www.ecfr.gov/current/title-21/chapter-II/part-1308/section-1308.111
- 21 CFR § 1308.11(d) — Schedule I Hallucinogenic Substances (including mephedrone and isomer definition). (n.d.). https://www.law.cornell.edu/cfr/text/21/1308.1112
Further Reading
Brandt et al. 2020 - Pharmacological profiling of ortho-mephedrone (2-MMC)
Eshleman et al. 2013 - Substituted methcathinones differ in transporter and receptor interactions
Eshleman et al. 2013 – Substituted cathinones as monoamine transporter substrates
EUDA: Initial Report - 2-Methylmethcathinone (2-MMC)
NDEWS: Web Monitoring Alert - Online mentions of 2-MMC
Simmler et al. 2014 - Monoamine transporter and receptor interaction profiles of designer cathinones
User reports compilation – r/ResearchChemicals: “2-MMC turns me into a sex fiend” (Reddit, 2024)
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 2-MMC article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.